Loading instrument data

INAF

Unavailable

Indofarma Tbk available

126

+0.0% 90d · 2026-10-01

Snapshot·market data through 2026-10-01·Coverage varies by issuer; missing evidence remains visible.

View flow observations

Date	Net flow

Insider buys (90d)

Rp0

Insider sells (90d)

Rp0

Net foreign flow (90d)

Rp0

net foreign buyer

Reported shareholders

8,695

Δ 3 last month

Free float

5.6%

low float, thin public liquidity

Exit Watch

—low coverage14-day window 2026-09-17 → 2026-10-01 · coverage 0.00

FF<20%SPARSE

Cohort net flow (0 sessions)

No daily labeled-broker detail for this issuer: aggregate top-broker feeds were used for the score instead.

Components

instExit—

Market capitalization is unavailable for normalization.

foreignExit—

Foreign-flow observations are unavailable in the window.

insiderExit—

No insider transactions reported in the 90-day window.

retailAbsorb—

Market capitalization is unavailable for normalization.

Context

SUSP 2024-07-02 Suspend more than 6 month source ↗
AGM 2026-10-29

Index evidence

Reported ownership (90d) 30%Unavailable

Foreign flow (90d) 25%Unavailable

Broker context (14d) 20%Unavailable

Shareholder count change 15%Unavailable

Foreign holder-class shift 10%+0.13σ

σ = robust cohort z-score, clipped to ±3; unavailable components do not contribute.

Holder composition (monthly)

foreign institutional holdersmonthly

Reported ownership

major reported holders

PT Bio Farma (Persero)	0.81%	Rp315.0B
PT Asabri (Persero) - Dapen Tni	0.14%	Rp53.7B
Public	0.06%	Rp21.8B

institutional net transactionsmonthly

No institutional transaction flow reported.

Reported ownership transactions

Transaction date	Holder	Type	Shares	Price	Value	Filed at	Source
No reported ownership transactions in the saved snapshot.